Alpha Teknova (TKNO) Change in Receivables (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Change in Receivables of $1.1 million for Q1 2026, down 21.35% year-over-year from $1.3 million in Q1 2025, and up 304.04% quarter-over-quarter from -$520000.0 in Q4 2025.
Alpha Teknova (TKNO) Change in Receivables (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Change in Receivables for 7 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 21.35% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $86000.0 (down 92.97% YoY), while the FY2025 annual figure was $374000.0, down 24.29% from the prior year.
- Change in Receivables grew to $1.1 million in Q1 2026 per TKNO's latest filing, from -$520000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $1.3 million in Q1 2025 and bottomed at -$1.3 million in Q4 2022.
- Historically, Change in Receivables has averaged $73941.2 across 5 years, with a median of $13000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Receivables sank 1330.56% — and 2023, when it soared 277.09%.
- Alpha Teknova's Change in Receivables stood at -$1.3 million in 2022, then grew by 23.78% to -$1.0 million in 2023, then soared by 77.89% to -$224000.0 in 2024, then tumbled by 132.14% to -$520000.0 in 2025, then soared by 304.04% to $1.1 million in 2026.
- Business Quant data shows TKNO's Change in Receivables at $1.1 million in Q1 2026, -$520000.0 in Q4 2025, and $17000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 378.66 Mn | 361.23 Mn | 4.89 Mn | -266,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -266,000.00 |
| Jun 30, 2026 | -266,000.00 |
| Mar 31, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | -520,000.00 |
| Dec 31, 2025 | -520,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | -472,000.00 |
| Jun 30, 2025 | -472,000.00 |
| Mar 31, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | -224,000.00 |
| Dec 31, 2024 | -224,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 86,000.00 |
| Jun 30, 2024 | 86,000.00 |
| Mar 31, 2024 | 619,000.00 |
| Mar 31, 2024 | 619,000.00 |